StageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023 Newsfile - Thu Feb 2, 2:14PM CST
Newsfile
Thu Feb 2, 2:14PM CST
Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announced today that its...
StageZero Life Sciences: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (SZLS) The Globe and Mail - Mon Jan 23, 10:07AM CST
The Globe and Mail
Mon Jan 23, 10:07AM CST
StageZero Life Sciences is now ranked among the top 10 undervalued stocks in the Medical Diagnostics & Research industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its...
StageZero Life Sciences: Top 10 Undervalued Nano Cap Stocks on TSX (SZLS) The Globe and Mail - Sat Jan 21, 10:23AM CST
The Globe and Mail
Sat Jan 21, 10:23AM CST
StageZero Life Sciences is now ranked among the top 10 nano cap stocks on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a...